NYSE:NSRX | Income Statement | Nasus Pharma Ltd

Complete source-backed income-statement history.

Available history
2023-12-31 to 2025-12-31
Data captured

Historical Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares

Annual Income Statement

DateRevenueCost of revenueGross profitR&D expenseSG&A expenseOperating expensesOperating incomeNonoperating income/expensePre-tax incomeIncome taxNet incomeBasic EPSDiluted EPSBasic sharesDiluted shares
2025-12-31$1.24B$2.24M$4.9M-$4.9M-$5.86M-$0.72-$0.728,010,1268,010,126
2024-12-31$335,000.00$1.08M-$1.08M-$1.53M-$0.22-$0.227,027,7257,027,725
2023-12-31$567,000.00$1.15M-$1.15M-$1.05M-$0.15-$0.206,889,7087,057,820